Literature DB >> 17237411

Slamf1, the NKT cell control gene Nkt1.

Margaret A Jordan1, Julie M Fletcher, Daniel Pellicci, Alan G Baxter.   

Abstract

Invariant NKT cells play a critical role in controlling the strength and character of adaptive immune responses. We have previously reported deficiencies in the numbers and function of NKT cells in the NOD mouse strain, which is a well-validated model of type 1 diabetes and systemic lupus erythematosus. Genetic control of thymic NKT cell numbers was mapped to two linkage regions: Nkt1 on distal chromosome 1 and Nkt2 on chromosome 2. In this study, we report the production and characterization of a NOD.Nkrp1(b).Nkt1(b) congenic mouse strain, apply microarray expression analyses to limit candidate genes within the 95% confidence region, identify Slamf1 (encoding signaling lymphocyte activation molecule) and Slamf6 (encoding Ly108) as potential candidates, and demonstrate retarded signaling lymphocyte activation molecule expression during T cell development of NOD mice, resulting in reduced expression at the CD4(+)CD8(+) stage, which is consistent with decreased NKT cell production and deranged tolerance induction in NOD mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237411     DOI: 10.4049/jimmunol.178.3.1618

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function.

Authors:  Idil Aktan; Alan Chant; Zachary D Borg; David E Damby; Paige C Leenstra; Graham W J Lilley; Graham W G Lilley; Joseph Petty; Benjamin T Suratt; Cory Teuscher; Edward K Wakeland; Matthew E Poynter; Jonathan E Boyson
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Authors:  Y-G Chen; S-W Tsaih; D V Serreze
Journal:  Genes Immun       Date:  2011-09-22       Impact factor: 2.676

Review 3.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

4.  The role of CD1d-restricted NKT cells in the clearance of Pseudomonas aeruginosa from the lung is dependent on the host genetic background.

Authors:  Patrick Benoit; Vaia Yioula Sigounas; Jenna L Thompson; Nico van Rooijen; Matthew E Poynter; Matthew J Wargo; Jonathan E Boyson
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

5.  Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice.

Authors:  Yi-Guang Chen; John P Driver; Pablo A Silveira; David V Serreze
Journal:  Immunogenetics       Date:  2007-07-10       Impact factor: 2.846

6.  Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells.

Authors:  Cristina Ferreira; Yogesh Singh; Anna L Furmanski; F Susan Wong; Oliver A Garden; Julian Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

Review 7.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

Review 8.  Control of early stages in invariant natural killer T-cell development.

Authors:  Taishan Hu; Idoia Gimferrer; José Alberola-Ila
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

Review 9.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

10.  The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage.

Authors:  Taishan Hu; Amie Simmons; Joan Yuan; Timothy P Bender; Jose Alberola-Ila
Journal:  Nat Immunol       Date:  2010-04-11       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.